Correlation Between Inozyme Pharma and Revelation Biosciences
Can any of the company-specific risk be diversified away by investing in both Inozyme Pharma and Revelation Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inozyme Pharma and Revelation Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inozyme Pharma and Revelation Biosciences, you can compare the effects of market volatilities on Inozyme Pharma and Revelation Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inozyme Pharma with a short position of Revelation Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inozyme Pharma and Revelation Biosciences.
Diversification Opportunities for Inozyme Pharma and Revelation Biosciences
-0.77 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Inozyme and Revelation is -0.77. Overlapping area represents the amount of risk that can be diversified away by holding Inozyme Pharma and Revelation Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Revelation Biosciences and Inozyme Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inozyme Pharma are associated (or correlated) with Revelation Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Revelation Biosciences has no effect on the direction of Inozyme Pharma i.e., Inozyme Pharma and Revelation Biosciences go up and down completely randomly.
Pair Corralation between Inozyme Pharma and Revelation Biosciences
Given the investment horizon of 90 days Inozyme Pharma is expected to under-perform the Revelation Biosciences. But the stock apears to be less risky and, when comparing its historical volatility, Inozyme Pharma is 2.09 times less risky than Revelation Biosciences. The stock trades about -0.22 of its potential returns per unit of risk. The Revelation Biosciences is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest 1.85 in Revelation Biosciences on December 4, 2024 and sell it today you would lose (0.15) from holding Revelation Biosciences or give up 8.11% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Inozyme Pharma vs. Revelation Biosciences
Performance |
Timeline |
Inozyme Pharma |
Revelation Biosciences |
Inozyme Pharma and Revelation Biosciences Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Inozyme Pharma and Revelation Biosciences
The main advantage of trading using opposite Inozyme Pharma and Revelation Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inozyme Pharma position performs unexpectedly, Revelation Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Revelation Biosciences will offset losses from the drop in Revelation Biosciences' long position.Inozyme Pharma vs. Beam Therapeutics | Inozyme Pharma vs. Editas Medicine | Inozyme Pharma vs. Caribou Biosciences | Inozyme Pharma vs. Verve Therapeutics |
Revelation Biosciences vs. Revelation Biosciences | Revelation Biosciences vs. SAB Biotherapeutics | Revelation Biosciences vs. Surrozen Warrant | Revelation Biosciences vs. Jasper Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
CEOs Directory Screen CEOs from public companies around the world | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data |